Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Goodwill: 2018-2025

Historic Goodwill for OptimizeRx (OPRX) over the last 8 years, with Q3 2025 value amounting to $70.9 million.

  • OptimizeRx's Goodwill fell 4.37% to $70.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.9 million, marking a year-over-year decrease of 4.37%. This contributed to the annual value of $70.9 million for FY2024, which is 955.63% down from last year.
  • Per OptimizeRx's latest filing, its Goodwill stood at $70.9 million for Q3 2025, which was down 4.37% from $70.9 million recorded in Q2 2025.
  • OptimizeRx's Goodwill's 5-year high stood at $78.4 million during Q4 2023, with a 5-year trough of $14.7 million in Q1 2021.
  • Its 5-year average for Goodwill is $42.1 million, with a median of $22.7 million in 2022.
  • Within the past 5 years, the most significant YoY rise in OptimizeRx's Goodwill was 24558.36% (2024), while the steepest drop was 955.63% (2024).
  • Quarter analysis of 5 years shows OptimizeRx's Goodwill stood at $14.7 million in 2021, then surged by 53.83% to $22.7 million in 2022, then skyrocketed by 245.58% to $78.4 million in 2023, then fell by 9.56% to $70.9 million in 2024, then changed by 0.0% to $70.9 million in 2025.
  • Its Goodwill was $70.9 million in Q3 2025, compared to $70.9 million in Q2 2025 and $70.9 million in Q1 2025.